Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009
Date:4/30/2009

$ (4,552) -------------------------------- d. Amortization of acquisition related intangible assets and medical technologies. e. Non-recurring in-process research and development expense relating to payments made to licensors and collaborators. f. Foreign exchange fluctuations on foreign currency net monetary assets. g. Realized loss on write-down of assets. h. Amortization of deferred financing costs. i. Tax effects of adjustments a. through h. for the period. ANGIOTECH PHARMACEUTICALS, INC. CALCULATION OF ADJUSTED EBITDA (unaudited) Three months ended March 31, (in thousands of U.S.$) 2009 2008 -------------------------------------------- ---------------------------- Net loss on a GAAP basis $ 12,444 (15,763) Interest expense on long-term debt 10,044 12,120 Income tax expense (recovery) 5,724 (3,814) Depreciation and amortization 9,161 9,448 -------------------------------------------- ---------------------------- EBITDA 37,373 1,991 Adjustments: Non-recurring revenue, net of license fees (25,053) (53) In-process research and development - 2,500 Non-recurring research and development 313 625 Stock-based compensation 384 817 Litigation expenses 747 1,598 Foreign exchange loss (gain) (732) (423) Investment and other income 15 (
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Angiotech announces date of annual general meeting of shareholders
2. Angiotech Pharmaceuticals, Inc. Announces Conference Call And Webcast
3. Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
4. Angiotech announces positive results from Bio-Seal(TM) clinical study
5. Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
6. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
7. Angiotech Pharmaceuticals announces time change of conference call and webcast
8. Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners
9. Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
10. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
11. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... September 2, 2015 BiondVax Pharmaceuticals Ltd. ... National Institute of Allergy and Infectious Diseases (NIAID), part of ... of Health and Human Services (HHS), to launch a new ... United States in the 2015-16 timeframe. The trial ... Multimeric-001 (M-001), as a primer vaccine, which would be administered ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... efficiency of their entire waste to energy process and continue to contribute to ... Major Upgrade , Temarry’s Waste to Energy process has been operating at their ...
(Date:9/1/2015)... , ... September 02, 2015 , ... Spirax Sarco ... features to its eCommerce site Spirax Sarco Anytime. This platform, offering unique online ... to place your next order? Log on to Spirax Sarco Anytime and within ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... High-Content Imaging System. This transformative system fits a broad range of automated ... as spheroids, tissues, and organisms. , The ImageXpress Micro Confocal features ...
Breaking Biology Technology:BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Temarry Recycling’s New $100,000 Waste to Energy Renovation 2Spirax Sarco Announces New Features to Anytime Platform 2ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research 2ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research 3
... combines Avon,s FM53 mask with its ISI developed SCBA ... in modular respiratory protection, Avon Protection Systems - a ... (National Institute for Occupational Safety and Health) approval for ... its Avon-ISI division. The ST53 system combines Avon,s tactical ...
... March 10 PURE Bioscience (Nasdaq: ... President and CEO, will host a conference call ... to review and discuss second quarter 2009 financial ... interested parties may participate in the conference call ...
... March 10 BioInformatics, LLC announces availability of its ... Strategies for Life Science Suppliers. In ... research and advisory firm serving the life science market, ... and strategic -- decision-making for life science suppliers. BioInformatics, ...
Cached Biology Technology:Avon Protection Systems Receives NIOSH Approval for ST53 SCBA System 2Avon Protection Systems Receives NIOSH Approval for ST53 SCBA System 3PURE Bioscience Schedules Second Quarter 2009 Financial Results Conference Call for March 12, 2009 at 1:30 P.M. PDT 2New Report - Prospering in a Down Market: Strategies for Life Science Suppliers 2New Report - Prospering in a Down Market: Strategies for Life Science Suppliers 3
(Date:8/20/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market and creator of ... Smart Card Alliance and the EMV Migration Forum.  ... Smart Card Alliance Latin America (SCALA) Chapter provides NXT-ID, ... thought leaders promoting adoption of smart card technology. ...
(Date:8/12/2015)... Aug. 12, 2015   MedNet Solutions , an ... spectrum of clinical research, is proud to announce that ... comprehensive SaaS-based eClinical technology platform, has led the way ... two quarters of 2015.   Q2 2015 and Q1 ... measured by contract value sold in the company,s 15 ...
(Date:8/10/2015)... and TELTOW, Germany , ... Instruments (SMI), a world leader in Eye Tracking ... completion of its OEM Eye Tracking Platform for integration ... Tracking Platform contains reference designs for seamless integration of ... systems, virtual reality HMDs and augmented reality smart glasses. ...
Breaking Biology News(10 mins):NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3
... of a millimeter in diameter numerically dominate marine ... dioxide uptake, fueling the marine food web over ... published in this weeks PLoS ONE by post-doctoral ... scientists from MountAllison University, Sackville, New Brunswick, Canada, ...
... at The University of Texas Medical School at Houston ... and spina bifida. The decade-long study looked at more ... with that birth defect. UT Medical School researchers ... in glucose metabolism to look for a link between ...
... The Argentine ant, Linepithema humile, is one of the most ... five continents in addition to its native range in South ... its success. The findings, from researchers at the University ... appear this week in the Proceedings of the National Academy ...
Cached Biology News:Variable light illuminates the distribution of picophytoplankton 2UT-Houston's Northrup and colleagues uncover genetic link to spina bifida 2Ant invaders eat the natives, then move down the food chain 2
...
... 5-OxoETE-d7 is used as an internal standard ... isotope dilution mass spectrometry. 5-OxoETE is a ... of 5-HETE in human neutrophils. It stimulates ... EC50 of 2 nM. 5-OxoETE selectively stimulates ...
Mouse monoclonal antibody raised against a full length recombinant ATF3. NCBI Entrez Gene ID = ATF3...
... The pAcAB4 vector is a 10.0 kb ... contains two,copies of the AcNPV polyhedrin promoter ... the first p10,promoter is a Sma I ... sequences. Upstream of this,an inverted polyhedrin promoter ...
Biology Products: